ティーセルヌーヴォー株式会社
T Cell Nouveau is a clinical-stage biopharmaceutical company that focuses on curing solid tumors with hybrid CAR-T cell therapy.
ティーセルヌーヴォー株式会社 is a company in medtech based in Tokyo, Japan, founded in 2021.
Profile
"T Cell Nouveau is a pioneering medtech company dedicated to revolutionizing cancer treatment. Leveraging cutting-edge technology and precise cellular power, we are developing a novel CAR-T cell therapy targeting the cancer antigen GD2. Our research enables specific attacks on intracellular cancer, enhancing the efficiency and safety of cancer treatment. Committed to organizational growth and evolution, we continuously strive for innovation through initiatives such as website renewal and executive appointments. Headquartered in Tokyo, we can be reached at +81-3-6555-3304. Join us in our mission to provide innovative solutions for curing solid tumors with hybrid CAR-T cell therapy."
ティーセルヌーヴォー株式会社 is positioned in medtech, a segment that rewards a clear, focused offering.
The company is recorded as being based in Tokyo, Japan.
It is recorded at the Plug and Play portfolio startup stage.
The company reports a headcount in the 1-10 range.
| Sector | Medtech |
|---|---|
| Headquarters | Tokyo, Japan |
| Country | Japan |
| Founded | 2021 |
| Employees | 1-10 |
| Stage | Plug and Play portfolio startup |
Website: www.tcellnouveau.com
Browse related
Create a free account